Revenue Near Zero as Commercial Operations Have Not Yet Commenced
Revenue fell 95.8% YoY to just $565K in Q1 FY2026 from $13.4M in the prior-year period, and gross profit collapsed 99.7% to $21K, indicating SMR has effectively transitioned to a pre-revenue development stage with minimal commercial activity generating income.
Operating Losses Deepened Significantly
Operating loss widened 62.8% YoY to -$57.5M from -$35.3M, driven by rising R&D expenditures (up 40.2% to $12.8M) and operating expenses that vastly exceed the negligible revenue base, reflecting heavy investment in nuclear technology development.
Massive Cash Burn from Operations and Investing Activities
Operating cash outflow surged to -$314.7M from -$22.8M in the prior year (a 1,281% deterioration), while investing cash outflow reached -$218.4M versus a prior-year inflow of $9.9M, signaling large-scale capital deployment into development assets and infrastructure.